Welcome to BioMarin’s Investor Relations & Media Page

We’ve brought together a variety of information in one location to better assist you in your efforts to research and develop news articles and learn about our company.

BioMarin Pharmaceutical Inc. was founded in 1997, and since July 1999 the company's common stock has been traded on the Nasdaq National Market under the ticker symbol BMRN. BioMarin's policy is to fully comply with all rules put forth by the Securities and Exchange Commission and the Nasdaq National Market. For misplaced stock certificates, please contact our transfer agent directly.

Recent News
Feb 25, 2021
BioMarin Announces Fourth Quarter and Record Full-year 2020 Financial Results and Corporate Updates

Financial Highlights (in millions of U.S. dollars, except per share data, unaudited) Three Months Ended December 31, Twelve Months Ended December 31, 2020 2019 % Change 2020 2019 % Change Total...

Feb 24, 2021
BioMarin to Participate in Four Upcoming Virtual Investor Conferences

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in four upcoming virtual conferences. An audio webcast of the presentations will be available live. You...

Feb 18, 2021
BioMarin Appoints Former Goldman Sachs Partner and Life Sciences Executive, Maykin Ho, Ph.D. to Board of Directors

BioMarin Pharmaceutical Inc. (Nasdaq:BMRN), a global leader in providing therapies for rare genetic diseases, today announced the appointment of former Goldman Sachs partner and executive in the...

Events & Presentations
Cowen 41st Annual Health Care Conference
Thursday, March 4, 2021
12:50pm - 1:20pm EST
Add to Calendar
Set Email Reminder
Barclays Global Healthcare Conference
Tuesday, March 9, 2021
2:25pm - 2:50pm EST
Add to Calendar
Set Email Reminder

Stock Quote
NASDAQBMRN